ConvaTec receives FDA clearance to market hydrofiber wound dressing.ConvaTec, Inc., a Bristol-Myers Squibb Bristol-Myers Squibb (NYSE: BMY), colloquially referred to as BMS, is a pharmaceutical corporation, formed by a 1989 merger between pharmaceutical companies Bristol-Myers Company, founded in 1887 by William McLaren Bristol and John Ripley Myers in Clinton, NY (both were company, Skillman, NJ, announced the FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. has cleared Aquacel Ag, a antimicrobial wound dressing, for marketing in the US. The dressing is for use in acute and chronic wounds including partial-thickness burns, surgical wounds, diabetic foot diabetic foot A foot with a constellation of pathologic changes affecting the lower extremity in diabetics, often leading to amputation and/or death due to complications; the common initial lesion leading to amputation is a nonhealing skin ulcer, induced by , leg, and pressure ulcers. The company says Aquacel helps reduce wound infection. Aquacel AG is the only antimicrobial dressing that offering the unique gelling properties of Hydrofiber technology, the company reports. The Hydrofiber dressing absorbs up to 20 times its weight in fluid and retains wound fluid by a hydrophilic hydrophilic /hy·dro·phil·ic/ (-fil´ik) readily absorbing moisture; hygroscopic; having strongly polar groups that readily interact with water. hy·dro·phil·ic adj. action. Contact: Chick Goebel - (610) 558-3447 |
|
||||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion